Mary Ann Liebert: Engineered Capsids for Efficient Gene Delivery to the Eye
August 14, 2020
August 14, 2020
NEW ROCHELLE, New York, Aug. 14 -- Mary Ann Liebert Inc. issued the following news release:
A rational design approach created novel variants of adeno-associated viral (AAV) capsids. These have improved transduction properties in the mouse retina and cornea. as reported in the peer-reviewed journal Human Gene Therapy.
Click here (https://www.liebertpub.com/doi/10.1089/hum.2020.070) to read the full-text article free on the Human Gene Therapy website through September 1 . . .
A rational design approach created novel variants of adeno-associated viral (AAV) capsids. These have improved transduction properties in the mouse retina and cornea. as reported in the peer-reviewed journal Human Gene Therapy.
Click here (https://www.liebertpub.com/doi/10.1089/hum.2020.070) to read the full-text article free on the Human Gene Therapy website through September 1 . . .